1-4 of 4
Elizabeth M. Van Cott, MD
Close
Sort by
Journal Articles

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19

Hanny Al-Samkari, MD, Fei Song, MD, Elizabeth M. Van Cott, MD, David J. Kuter, MD, Rachel P. Rosovsky, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-134605
Published: 2020
Journal Articles

The Incidence of Thrombosis in Patients with Isolated Heparin Induced Thrombocytopenia.

Rachel P. Rosovsky, MD, Omar I. Abdel-Wahad, MD, Elizabeth M. Van Cott, MD, David J. Kuter, MD
Journal: Blood
Blood (2006) 108 (11): 1049.
https://doi.org/10.1182/blood.V108.11.1049.1049
Published: 2006
Journal Articles

The Identification of Hypercoagulable Markers in Patients with Malignant Gliomas and Venous Thromboembolism.

Rachel P. Rosovsky, MD, Patrick Wen, MD, Santosh Kesari, MD, Elizabeth M. Van Cott, MD, David J. Kuter, MD
Journal: Blood
Blood (2006) 108 (11): 4097.
https://doi.org/10.1182/blood.V108.11.4097.4097
Published: 2006
Journal Articles

Two Cases of Pediatric Hit Requiring Unusually High Doses of Direct Thrombin Inhibitors: Does a Subset of Such Patients Exist?.

Eric F. Grabowski, MD, ScD, Ferdinando S. Buonanno, MD, Daniel Doody, MD, Elizabeth M. Van Cott, MD, PhD, Patricia E. Grant, MD, Robin M. Jones, MD, Michael Whalen, MD, Natan Nowiski, MD
Journal: Blood
Blood (2005) 106 (11): 4161.
https://doi.org/10.1182/blood.V106.11.4161.4161
Published: 2005